On ECHEMI
Home > Drugs > YANGTZE River Pharmaceutical Group Jiangsu JOINT STOCK Co., Ltd.
YANGTZE River Pharmaceutical Group Jiangsu JOINT STOCK Co., Ltd.
  • Founded in:

    1994-07-28
  • Country:

    China China
  • Address:

    No. 2 Tongjiang East Road, Gaogang District, Taizhou City, Jiangsu Province
  • Tax NO.:

    91321200703973749K
  • Registered Funds:

    202.679 million yuan
  • Website:

  • Email:

Related Drugs
Children's cough granules
Aster, Stemona, loquat leaf, Peucedanum, Licorice, Bitter Apricot, Platycodon, Ephedra, Polygonum indigo leaf.
Name Description Content CAS NO. Registered Holders
aster

0
STEMONAE RADIX

0
Loquat leaves

0
PEUCEDANI RADIX

0
DGL

0
ARMENIACAE SEMEN AMARUM

0
Platycodonis Radix

0
Ephedra

0
Polygonum aviculare extract

0
Weisu Granules
Perilla stem, Cyperus rotundus, dried orange peel, Citron, Citron, Citron, Citrus aurantium, Citrus aurantium, Areca nut, stir-fried chicken gizzard lining. For more auxiliary materials, please refer to the instructions.
Name Description Content CAS NO. Registered Holders
PERILLAE CAULIS

0
CYPERI RHIZOMA

0
Citri reticulatae pericarpium

0
Citri Fructus

0
Citri Sarcodactylis Fructus

0
AURANTII FRUCTUS

0
Arecae Semen

0
Fried Chicken Gizzard

0
Retinoic acid cream
The main ingredient of this product is all-trans retinoic acid. Its chemical name is: 3,7-dimethyl-9 (2,6,6-trimethylcyclohexene)-2,4,6,11-all-trans nonatetraenoic acid.
Name Description Content CAS NO. Registered Holders
Retinoic acid

It can promote epidermal cell renewal, regulate epidermal cell proliferation and differentiation, make stratum corneum cells loose and easy to fall off, which is beneficial for removing acne and inhibiting the formation of new acne.

More

It can promote epidermal cell renewal, regulate epidermal cell proliferation and differentiation, make stratum corneum cells loose and easy to fall off, which is beneficial for removing acne and inhibiting the formation of new acne.

302-79-4 12
Diclofenac Potassium Tablets
The main ingredient of this product is diclofenac potassium
Name Description Content CAS NO. Registered Holders
Diclofenac potassium

Inhibits cyclooxygenase activity, thereby blocking the conversion of arachidonic acid to prostaglandins; promotes the combination of arachidonic acid and triglycerides, reduces the concentration of free arachidonic acid in cells, and indirectly inhibits the synthesis of leukotrienes; the inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

More

Inhibits cyclooxygenase activity, thereby blocking the conversion of arachidonic acid to prostaglandins; promotes the combination of arachidonic acid and triglycerides, reduces the concentration of free arachidonic acid in cells, and indirectly inhibits the synthesis of leukotrienes; the inhibitory effect on prostaglandin synthesis is stronger than that of aspirin and indomethacin.

15307-81-0 24
Enalapril Maleate Tablets
The main ingredient of this product is: Enalapril Maleate. Its chemical name is: Enalapril Maleate; N-[(S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-L-proline (Z)-2-butenedioate (1:1). Molecular formula: C20H28N2O5C4H4O4.
Name Description Content CAS NO. Registered Holders
Enalapril maleate

This product is an angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on rat models of renal hypertension II, renal hypertension I, and spontaneous hypertension.

More

This product is an angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on rat models of renal hypertension II, renal hypertension I, and spontaneous hypertension.

76095-16-4 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.